Passenger Deletions Generate Therapeutic Vulnerabilities in Cancer

Established the principle of “collateral lethality” and identified ENO2 as a target for therapeutic intervention by demonstrating that ENO2-depleation selectively inhibited growth, survival and the tumorigenic potential of ENO1-deleted GBM cells.

Read the Abstract

Download the PDF

Get Insights From Ron

Sign up for the latest news and updates from Ron DePinho, MD